EP3340984A4 - Verfahren zur behandlung von opioidabhängigkeit und entzug mittels noribogain - Google Patents

Verfahren zur behandlung von opioidabhängigkeit und entzug mittels noribogain Download PDF

Info

Publication number
EP3340984A4
EP3340984A4 EP16793477.7A EP16793477A EP3340984A4 EP 3340984 A4 EP3340984 A4 EP 3340984A4 EP 16793477 A EP16793477 A EP 16793477A EP 3340984 A4 EP3340984 A4 EP 3340984A4
Authority
EP
European Patent Office
Prior art keywords
noribogaine
withdrawal
treatment
methods
opioid dependency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16793477.7A
Other languages
English (en)
French (fr)
Other versions
EP3340984A1 (de
Inventor
Holger Weis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DemeRx Inc
Original Assignee
DemeRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DemeRx Inc filed Critical DemeRx Inc
Publication of EP3340984A1 publication Critical patent/EP3340984A1/de
Publication of EP3340984A4 publication Critical patent/EP3340984A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP16793477.7A 2015-05-11 2016-05-11 Verfahren zur behandlung von opioidabhängigkeit und entzug mittels noribogain Withdrawn EP3340984A4 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562159905P 2015-05-11 2015-05-11
US201562165853P 2015-05-22 2015-05-22
US201562180579P 2015-06-16 2015-06-16
US201562247130P 2015-10-27 2015-10-27
US201562260182P 2015-11-25 2015-11-25
PCT/US2016/031932 WO2016183244A1 (en) 2015-05-11 2016-05-11 Methods for treatment of opioid dependency and withdrawal using noribogaine

Publications (2)

Publication Number Publication Date
EP3340984A1 EP3340984A1 (de) 2018-07-04
EP3340984A4 true EP3340984A4 (de) 2019-06-19

Family

ID=57248533

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16793477.7A Withdrawn EP3340984A4 (de) 2015-05-11 2016-05-11 Verfahren zur behandlung von opioidabhängigkeit und entzug mittels noribogain

Country Status (3)

Country Link
EP (1) EP3340984A4 (de)
CA (1) CA3024081A1 (de)
WO (1) WO2016183244A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185085A1 (en) * 1997-09-04 2007-08-09 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
US20150045350A1 (en) * 2013-03-15 2015-02-12 Demerx, Inc. Method for noribogaine treatment in patients on methadone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012024401A2 (en) * 2010-08-17 2012-02-23 University Of Florida Research Foundation, Inc. Intelligent drug and/or fluid delivery system to optimizing medical treatment or therapy using pharmacodynamic and/or pharmacokinetic data
US10702485B2 (en) * 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185085A1 (en) * 1997-09-04 2007-08-09 Novoneuron, Inc. Noribogaine in the treatment of pain and drug addiction
US20150045350A1 (en) * 2013-03-15 2015-02-12 Demerx, Inc. Method for noribogaine treatment in patients on methadone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016183244A1 *

Also Published As

Publication number Publication date
EP3340984A1 (de) 2018-07-04
WO2016183244A1 (en) 2016-11-17
CA3024081A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
EP3454945A4 (de) Ash11-inhibitoren und verfahren zur behandlung damit
HK1253049A1 (zh) 糖基相互作用化合物及其使用方法
IL261343A (en) Transposon system and methods of use
EP3218005A4 (de) Glycaninteragierende verbindungen und verfahren zur verwendung
GB201514760D0 (en) Compounds and method of use
ZA201606322B (en) Methods for acute and long-term treatment of drug addiction
GB201609786D0 (en) Compounds and method of use
EP3133919A4 (de) Mittel und verfahren zur behandlung von pathogenen
EP3291740A4 (de) Gewebeentfernungsvorrichtung und verfahren zur verwendung
EP3265476A4 (de) Protoxin-vii-varianten und verfahren zur verwendung
EP3237020A4 (de) Plasmabehandlungsvorrichtung und verfahren zur behandlung von artikeln
EP3328253A4 (de) Toilettenvorrichtung und verfahren zur verwendung
EP3185872A4 (de) Formulierungen von testosteron und behandlungsverfahren damit
EP3277304A4 (de) Protoxin-vii-varianten und verfahren zur verwendung
EP3226752A4 (de) Elektrodenplatzierung und behandlungssystem sowie verfahren zur verwendung davon
EP3134108A4 (de) Wirkstoffe und behandlungsverfahren
EP3302458A4 (de) Verfahren zur prävention und behandlung von autoimmunität
HK1247119A1 (zh) 一種治療方法和用於所述治療方法中的化合物
EP3236963A4 (de) Verfahren zur behandlung
EP3092593A4 (de) Vorrichtung und verfahren zum entriegeln einer vorrichtung
GB2544343B (en) Receptacle and its method of manufacture
SG11201608771WA (en) Method and device for plasma treatment of substrates
EP3370808A4 (de) Sicherheitsnadeln und verfahren zur verwendung davon
EP3373947A4 (de) Verbindungen und verfahren zur behandlung von schmerz
EP3340984A4 (de) Verfahren zur behandlung von opioidabhängigkeit und entzug mittels noribogain

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180514

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190521

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20190515BHEP

Ipc: A61K 31/485 20060101ALI20190515BHEP

Ipc: A61K 31/55 20060101ALI20190515BHEP

Ipc: A61K 31/6615 20060101ALI20190515BHEP

Ipc: A61P 25/36 20060101ALI20190515BHEP

Ipc: A61K 31/407 20060101AFI20190515BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191218